SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices approach all-time highs, fueled by speculation around potential Fed rate cuts and renewed interest in precious metals as a hedge against economic uncertainty. Community members are discussing technical breakouts, potential for a silver squeeze, and historical inflation-adjusted valuations, while some express concerns about market manipulation and potential pullbacks. The broader context involves increased industrial demand for silver and its role as a safe-haven asset amid global economic concerns.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is gaining attention as users discuss the potential of earning crypto through physical activity. Community members highlight the project's long-term potential and token burn events, while others suggest it's currently undervalued. Discussions also revolve around the mechanics of earning $SWEAT and its availability on various exchanges.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne ($S) is garnering attention as investors debate its valuation and potential for growth within the cybersecurity sector. Community discussions revolve around upcoming earnings and whether it will trigger a breakout, with some speculating on a potential buyout given its perceived undervaluation compared to competitors. Despite positive developments, concerns linger around management and consistent profitability.

Global X Funds - Global X Funds Global X Robotics & Artificial Intelligence ETF

Global X Funds Global X Robotics & Artificial Intelligence ETF

$BOTZ is trending as investors weigh the potential of AI and robotics against concerns of a possible tech bubble and broader economic weakness. Discussions revolve around the ETF's key holdings, including NVDA, and its exposure to the US-China AI arms race, with community members analyzing its long-term growth prospects.

SPDR Series Trust - State Street SPDR S&P Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF

XOP is trending amid geopolitical tensions and shifting supply dynamics, with potential impacts from Iranian oil exports and OPEC+ production decisions driving market speculation. Community members are weighing the possibilities of further output cuts and debating the sector's undervaluation. Bullish investors are monitoring the ETF for potential breakouts, while others are cautious about demand in China and wider economic factors.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley ($MS) is trending amid discussions around bank regulations, potential M&A activity, and analysts weighing in on its financial outlook and strategic shifts. The community is focused on institutional ownership, potential earnings catalysts, and its position relative to competitors like Goldman Sachs ($GS). Recent news includes Morgan Stanley expanding crypto access and analysts adjusting price targets, driving both bullish and bearish sentiment.

SSgA Active Trust - Health Care Select Sector SPDR

Health Care Select Sector SPDR Fund

The Health Care Select Sector SPDR Fund ($XLV) is trending amid discussions of sector rotation and potential breakout opportunities, particularly as some analysts suggest a shift from technology into healthcare. Community members are actively trading call options on XLV, targeting higher price levels, while also weighing in on potential impacts from healthcare policy and individual companies within the sector. There is also discussion that a recent top may need to be retested.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is trending as the community discusses its long-term potential, interoperability and recent supply cap implementation.  Some investors view it as a solid project for cross-chain applications, while others are weighing its potential against emerging Layer 1 solutions focused on high-speed settlement and compliance.

Oxford Lane Capital Corp. is a closed-end management investment company, which engages in investing in debt and equity tranches of collateralized loan obligation vehicles. The company was founded on June 9, 2010 and is headquartered in Greenwich, CT.

Oxford Lane Capital Corp

OXLC is trending as investors weigh the impact of high dividend payouts and a recent reverse stock split. Community discussions revolve around the stock's potential for recovery, with some expressing concerns about long-term price erosion and others highlighting the potential for high yields if the dividend remains stable. Broader market factors, like interest rate decisions and sector-specific news, are also influencing investor sentiment.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is trending as traders discuss potential breakouts and a possible shift in global market dynamics favoring Chinese equities amid trade discussions. Bullish sentiment is fueled by signals of government support and potential for policy easing, while some analysts point to oversold conditions and attractive valuations compared to US tech. Community members are actively trading options and discussing key price levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AstraZeneca or Merck: Which Oncology Giant Has the Edge? 

AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.

Summit Therapeutics PLC (NASDAQ:SMMT) Given Consensus Recommendation of "Hold" by Analysts

Shares of Summit Therapeutics PLC (NASDAQ:SMMT - Get Free Report) have received a consensus recommendation of "Hold" from the nineteen analysts that are currently covering the stock, MarketBeat.com...

Police & Firemen s Retirement System of New Jersey Purchases 24,163 Shares of Summit Therapeutics PLC $SMMT

Police & Firemen s Retirement System of New Jersey raised its position in Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) by 118.3% in the second quarter, according to the company in its most...

40,169 Shares in Summit Therapeutics PLC $SMMT Acquired by Neo Ivy Capital Management

Neo Ivy Capital Management bought a new stake in shares of Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the...

Catalyst Funds Management Pty Ltd Purchases New Position in Summit Therapeutics PLC $SMMT

Catalyst Funds Management Pty Ltd purchased a new position in shares of Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) during the second quarter, according to the company in its most recent...

Summit Therapeutics (NASDAQ:SMMT) Now Covered by Wolfe Research

Wolfe Research began coverage on shares of Summit Therapeutics in a research note on Tuesday. They issued a "peer perform" rating on the stock...

MRK Up Nearly 10% in a Month: Should You Buy, Sell or Hold the Stock?

Merck rebounds on pipeline wins and a $9.2B Cidara deal, but mixed trends and Keytruda risks keep investors weighing next moves.

Candriam S.C.A. Sells 324,755 Shares of Summit Therapeutics PLC $SMMT

Candriam S.C.A. decreased its holdings in shares of Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) by 38.7% in the 2nd quarter, according to the company in its most recent 13F filing with the...

Fiera Capital Corp Takes $16.66 Million Position in Summit Therapeutics PLC $SMMT

Fiera Capital Corp acquired a new position in Summit Therapeutics PLC (NASDAQ:SMMT - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the...

Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3?

Merck leans on Keytruda's expanding cancer indications and new SC formulation to sustain growth momentum into 2026 after soft sales in Q3.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

Current Price	$17.83
Prev Close	$17.82
Open	$18.02
Dividend Yield	0.00%
50-Day Moving Average	$19.47
Beta	1.18
Avg. Volume	3.59M
PE Ratio	-14.41

52-Week High	$36.91
52-Week Low	$15.55
Market Capitalization	$13.27B
EPS (Annual)	-$0.308
Price to Book	69.27
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

SMMT
Summit Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SMMT News

SMMTSummit Therapeutics Inc